Cancer and Leukemia Group B (CALGB) Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Chicago IL United States (1956)

Organization Overview

First Clinical Trial
1989
NCT00929591
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now